1: Wu C, Zhang K, Ye J, Huang X, Yang H, Yuan L, Wang H, Wang T, Zhong X, Guo J,
Yu L, Xiao A. Evaluating the effectiveness of stepwise swallowing training on
dysphagia in patients with Alzheimer's disease: study protocol for a randomized
controlled trial. Trials. 2022 Jun 13;23(1):490. doi:
10.1186/s13063-022-06446-y. PMID: 35698162; PMCID: PMC9195482.

2: Roberts AC, Rademaker AW, Salley EA, Mooney A, Morhardt D, Fried-Oken M,
Weintraub S, Mesulam M, Rogalski E. Communication Bridge™-2 (CB2): an NIH Stage
2 randomized control trial of a speech-language intervention for communication
impairments in individuals with mild to moderate primary progressive aphasia.
Trials. 2022 Jun 13;23(1):487. doi: 10.1186/s13063-022-06162-7. PMID: 35698099;
PMCID: PMC9190461.

3: Wang S, Chen H, Kong W, Ke F, Wei K. Identify Biomarkers of Alzheimer's
Disease Based on Multi-task Canonical Correlation Analysis and Regression Model.
J Mol Neurosci. 2022 Aug;72(8):1749-1763. doi: 10.1007/s12031-022-02031-9. Epub
2022 Jun 13. PMID: 35698015.

4: Lin H, Dixon SG, Hu W, Hamlett ED, Jin J, Ergul A, Wang GY. p38 MAPK Is a
Major Regulator of Amyloid Beta-Induced IL-6 Expression in Human Microglia. Mol
Neurobiol. 2022 Sep;59(9):5284-5298. doi: 10.1007/s12035-022-02909-0. Epub 2022
Jun 13. PMID: 35697992; PMCID: PMC9398979.

5: Ryu DW, Hong YJ, Cho JH, Kwak K, Lee JM, Shim YS, Youn YC, Yang DW. Automated
brain volumetric program measuring regional brain atrophy in diagnosis of mild
cognitive impairment and Alzheimer's disease dementia. Brain Imaging Behav. 2022
Jun 13. doi: 10.1007/s11682-022-00678-x. Epub ahead of print. PMID: 35697957.

6: Nelson PT, Brayne C, Flanagan ME, Abner EL, Agrawal S, Attems J, Castellani
RJ, Corrada MM, Cykowski MD, Di J, Dickson DW, Dugger BN, Ervin JF, Fleming J,
Graff-Radford J, Grinberg LT, Hokkanen SRK, Hunter S, Kapasi A, Kawas CH, Keage
HAD, Keene CD, Kero M, Knopman DS, Kouri N, Kovacs GG, Labuzan SA, Larson EB,
Latimer CS, Leite REP, Matchett BJ, Matthews FE, Merrick R, Montine TJ, Murray
ME, Myllykangas L, Nag S, Nelson RS, Neltner JH, Nguyen AT, Petersen RC,
Polvikoski T, Reichard RR, Rodriguez RD, Suemoto CK, Wang SJ, Wharton SB, White
L, Schneider JA. Frequency of LATE neuropathologic change across the spectrum of
Alzheimer's disease neuropathology: combined data from 13 community-based or
population-based autopsy cohorts. Acta Neuropathol. 2022 Jul;144(1):27-44. doi:
10.1007/s00401-022-02444-1. Epub 2022 Jun 13. PMID: 35697880.

7: Joutsa J, Moussawi K, Siddiqi SH, Abdolahi A, Drew W, Cohen AL, Ross TJ,
Deshpande HU, Wang HZ, Bruss J, Stein EA, Volkow ND, Grafman JH, van Wijngaarden
E, Boes AD, Fox MD. Brain lesions disrupting addiction map to a common human
brain circuit. Nat Med. 2022 Jun;28(6):1249-1255. doi:
10.1038/s41591-022-01834-y. Epub 2022 Jun 13. PMID: 35697842; PMCID: PMC9205767.

8: Winkler TW, Rasheed H, Teumer A, Gorski M, Rowan BX, Stanzick KJ, Thomas LF,
Tin A, Hoppmann A, Chu AY, Tayo B, Thio CHL, Cusi D, Chai JF, Sieber KB, Horn K,
Li M, Scholz M, Cocca M, Wuttke M, van der Most PJ, Yang Q, Ghasemi S, Nutile T,
Li Y, Pontali G, Günther F, Dehghan A, Correa A, Parsa A, Feresin A, de Vries
APJ, Zonderman AB, Smith AV, Oldehinkel AJ, De Grandi A, Rosenkranz AR, Franke
A, Teren A, Metspalu A, Hicks AA, Morris AP, Tönjes A, Morgan A, Podgornaia AI,
Peters A, Körner A, Mahajan A, Campbell A, Freedman BI, Spedicati B, Ponte B,
Schöttker B, Brumpton B, Banas B, Krämer BK, Jung B, Åsvold BO, Smith BH, Ning
B, Penninx BWJH, Vanderwerff BR, Psaty BM, Kammerer CM, Langefeld CD, Hayward C,
Spracklen CN, Robinson-Cohen C, Hartman CA, Lindgren CM, Wang C, Sabanayagam C,
Heng CK, Lanzani C, Khor CC, Cheng CY, Fuchsberger C, Gieger C, Shaffer CM,
Schulz CA, Willer CJ, Chasman DI, Gudbjartsson DF, Ruggiero D, Toniolo D,
Czamara D, Porteous DJ, Waterworth DM, Mascalzoni D, Mook-Kanamori DO, Reilly
DF, Daw EW, Hofer E, Boerwinkle E, Salvi E, Bottinger EP, Tai ES, Catamo E,
Rizzi F, Guo F, Rivadeneira F, Guilianini F, Sveinbjornsson G, Ehret G, Waeber
G, Biino G, Girotto G, Pistis G, Nadkarni GN, Delgado GE, Montgomery GW, Snieder
H, Campbell H, White HD, Gao H, Stringham HM, Schmidt H, Li H, Brenner H, Holm
H, Kirsten H, Kramer H, Rudan I, Nolte IM, Tzoulaki I, Olafsson I, Martins J,
Cook JP, Wilson JF, Halbritter J, Felix JF, Divers J, Kooner JS, Lee JJ,
O'Connell J, Rotter JI, Liu J, Xu J, Thiery J, Ärnlöv J, Kuusisto J,
Jakobsdottir J, Tremblay J, Chambers JC, Whitfield JB, Gaziano JM, Marten J,
Coresh J, Jonas JB, Mychaleckyj JC, Christensen K, Eckardt KU, Mohlke KL,
Endlich K, Dittrich K, Ryan KA, Rice KM, Taylor KD, Ho K, Nikus K, Matsuda K,
Strauch K, Miliku K, Hveem K, Lind L, Wallentin L, Yerges-Armstrong LM, Raffield
LM, Phillips LS, Launer LJ, Lyytikäinen LP, Lange LA, Citterio L, Klaric L,
Ikram MA, Ising M, Kleber ME, Francescatto M, Concas MP, Ciullo M, Piratsu M,
Orho-Melander M, Laakso M, Loeffler M, Perola M, de Borst MH, Gögele M, Bianca
M, Lukas MA, Feitosa MF, Biggs ML, Wojczynski MK, Kavousi M, Kanai M, Akiyama M,
Yasuda M, Nauck M, Waldenberger M, Chee ML, Chee ML, Boehnke M, Preuss MH,
Stumvoll M, Province MA, Evans MK, O'Donoghue ML, Kubo M, Kähönen M, Kastarinen
M, Nalls MA, Kuokkanen M, Ghanbari M, Bochud M, Josyula NS, Martin NG, Tan NYQ,
Palmer ND, Pirastu N, Schupf N, Verweij N, Hutri-Kähönen N, Mononen N, Bansal N,
Devuyst O, Melander O, Raitakari OT, Polasek O, Manunta P, Gasparini P, Mishra
PP, Sulem P, Magnusson PKE, Elliott P, Ridker PM, Hamet P, Svensson PO, Joshi
PK, Kovacs P, Pramstaller PP, Rossing P, Vollenweider P, van der Harst P,
Dorajoo R, Sim RZH, Burkhardt R, Tao R, Noordam R, Mägi R, Schmidt R, de Mutsert
R, Rueedi R, van Dam RM, Carroll RJ, Gansevoort RT, Loos RJF, Felicita SC,
Sedaghat S, Padmanabhan S, Freitag-Wolf S, Pendergrass SA, Graham SE, Gordon SD,
Hwang SJ, Kerr SM, Vaccargiu S, Patil SB, Hallan S, Bakker SJL, Lim SC, Lucae S,
Vogelezang S, Bergmann S, Corre T, Ahluwalia TS, Lehtimäki T, Boutin TS,
Meitinger T, Wong TY, Bergler T, Rabelink TJ, Esko T, Haller T, Thorsteinsdottir
U, Völker U, Foo VHX, Salomaa V, Vitart V, Giedraitis V, Gudnason V, Jaddoe VWV,
Huang W, Zhang W, Wei WB, Kiess W, März W, Koenig W, Lieb W, Gao X, Sim X, Wang
YX, Friedlander Y, Tham YC, Kamatani Y, Okada Y, Milaneschi Y, Yu Z; Lifelines
cohort study; DiscovEHR/MyCode study; VA Million Veteran Program, Stark KJ,
Stefansson K, Böger CA, Hung AM, Kronenberg F, Köttgen A, Pattaro C, Heid IM.
Differential and shared genetic effects on kidney function between diabetic and
non-diabetic individuals. Commun Biol. 2022 Jun 13;5(1):580. doi:
10.1038/s42003-022-03448-z. PMID: 35697829; PMCID: PMC9192715.

9: Cecon E, Fernandois D, Renault N, Coelho CFF, Wenzel J, Bedart C, Izabelle C,
Gallet S, Le Poder S, Klonjkowski B, Schwaninger M, Prevot V, Dam J, Jockers R.
Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage
of cerebral small vessels. Cell Mol Life Sci. 2022 Jun 13;79(7):361. doi:
10.1007/s00018-022-04390-3. PMID: 35697820; PMCID: PMC9191404.

10: Maher EE, Kipp ZA, Leyrer-Jackson JM, Khatri S, Bondy E, Martinez GJ,
Beckmann JS, Hinds TD Jr, Bimonte-Nelson HA, Gipson CD. Ovarian Hormones
Regulate Nicotine Consumption and Accumbens Glutamatergic Plasticity in Female
Rats. eNeuro. 2022 Jun 27;9(3):ENEURO.0286-21.2022. doi:
10.1523/ENEURO.0286-21.2022. PMID: 35697512; PMCID: PMC9239849.

11: Gannon M, Wang B, Stringfellow SA, Quintin S, Mendoza I, Srikantha T,
Roberts AC, Saito T, Saido TC, Roberson ED, Yacoubian TA. 14-3-3θ Does Not
Protect against Behavioral or Pathological Deficits in Alzheimer's Disease Mouse
Models. eNeuro. 2022 Jun 24;9(3):ENEURO.0368-21.2022. doi:
10.1523/ENEURO.0368-21.2022. PMID: 35697511; PMCID: PMC9233504.

12: Yang JJ, Keohane LM, Pan X, Qu R, Shu XO, Lipworth LP, Braun K, Steinwandel
MD, Dai Q, Shrubsole M, Zheng W, Blot WJ, Yu D. Association of Healthy
Lifestyles with Risk of Alzheimer Disease and Related Dementias in Low-Income
Black and White Americans. Neurology. 2022 Jun 13;99(9):e944–53. doi:
10.1212/WNL.0000000000200774. Epub ahead of print. PMID: 35697505; PMCID:
PMC9502739.

13: Koga S, Josephs KA, Aiba I, Yoshida M, Dickson DW. Neuropathology and
emerging biomarkers in corticobasal syndrome. J Neurol Neurosurg Psychiatry.
2022 Jun 13;93(9):919–29. doi: 10.1136/jnnp-2021-328586. Epub ahead of print.
PMID: 35697501; PMCID: PMC9380481.

14: Möllers T, Stocker H, Perna L, Rujescu D, Holleczek B, Schöttker B, Brenner
H. Subjective short-term memory difficulties at ages 50-75 predict dementia risk
in a community-based cohort followed over 17 years. Age Ageing. 2022 Jun
1;51(6):afac113. doi: 10.1093/ageing/afac113. PMID: 35697354.

15: Schmidt NB, Schubert FT, Sheffler JL. Brief, interoceptive exposure focused
treatment for anxiety in mild cognitive impairment. Age Ageing. 2022 Jun
1;51(6):afac133. doi: 10.1093/ageing/afac133. PMID: 35697353.

16: Zhu Y, Gao M, Huang H, Gao SH, Liao LY, Tao Y, Cheng H, Gao CY. p75NTR
Ectodomain Ameliorates Cognitive Deficits and Pathologies in a Rapid Eye
Movement Sleep Deprivation Mice Model. Neuroscience. 2022 Aug 1;496:27-37. doi:
10.1016/j.neuroscience.2022.06.009. Epub 2022 Jun 10. PMID: 35697320.

17: Liston A, Dooley J, Yshii L. Brain-resident regulatory T cells and their
role in health and disease. Immunol Lett. 2022 Aug;248:26-30. doi:
10.1016/j.imlet.2022.06.005. Epub 2022 Jun 10. PMID: 35697195.

18: Lin J, Niu Z, Xue Y, Gao J, Zhang M, Li M, Peng Y, Zhang S, Li W, Zhang Q,
Li X. Chronic vitamin D<sub>3</sub> supplementation alleviates cognition
impairment via inhibition of oxidative stress regulated by PI3K/AKT/Nrf2 in
APP/PS1 transgenic mice. Neurosci Lett. 2022 Jul 13;783:136725. doi:
10.1016/j.neulet.2022.136725. Epub 2022 Jun 10. PMID: 35697158.

19: Wang J, Wen C, Li J, Chen J, Feng Y. Automated quantification of brain
connectivity in Alzheimer's disease using ClusterMetric. Neurosci Lett. 2022 Aug
10;785:136724. doi: 10.1016/j.neulet.2022.136724. Epub 2022 Jun 10. PMID:
35697157.

20: Zhao L, Yue Z, Wang Y, Wang J, Ullah I, Muhammad F, Zhou Y, Zhu H, Wang X,
Li H. Autophagy activation by Terminalia chebula Retz. reduce Aβ generation by
shifting APP processing toward non-amyloidogenic pathway in APPswe transgenic
SH-SY5Y cells. Phytomedicine. 2022 Aug;103:154245. doi:
10.1016/j.phymed.2022.154245. Epub 2022 Jun 6. PMID: 35696798.

21: Gao W, Ma X, Yang H, Luan Y, Ai H. Molecular engineering and activity
improvement of acetylcholinesterase inhibitors: Insights from 3D-QSAR, docking,
and molecular dynamics simulation studies. J Mol Graph Model. 2022
Nov;116:108239. doi: 10.1016/j.jmgm.2022.108239. Epub 2022 Jun 2. PMID:
35696774.

22: Kam K, Jun J, Parekh A, Bubu OM, Mullins AE, Gu C, Pham L, Wisniewski TM,
Rapoport DM, Ayappa I, Osorio RS, Varga AW. Acute OSA Impacts Diurnal
Alzheimer's Biomarkers Through Nocturnal Hypoxemia and State Transitions. Am J
Respir Crit Care Med. 2022 Jun 13. doi: 10.1164/rccm.202202-0262LE. Epub ahead
of print. PMID: 35696622.

23: Smirnov DS, Salmon DP, Galasko D, Edland SD, Pizzo DP, Goodwill V, Hiniker
A. TDP-43 Pathology Exacerbates Cognitive Decline in Primary Age-Related
Tauopathy. Ann Neurol. 2022 Sep;92(3):425-438. doi: 10.1002/ana.26438. Epub 2022
Jul 11. PMID: 35696592; PMCID: PMC9391297.

24: Lee-Liu D. Preprint Highlight: Transcriptomic changes highly similar to
Alzheimer's disease are observed in a subpopulation of individuals during normal
brain aging. Mol Biol Cell. 2022 Jul 1;33(8):mbcP22031007. doi:
10.1091/mbc.P22-03-1007. PMID: 35696394.

25: Glover CM, Yu L, Stewart CC, Wilson RS, Bennett DA, Lamar M, Boyle PA.
Childhood socioeconomic status interacts with cognitive function to impact scam
susceptibility among community-dwelling older adults. Aging Ment Health. 2022
Jun 13:1-6. doi: 10.1080/13607863.2022.2087206. Epub ahead of print. PMID:
35696371.

26: Saleem S, Banerjee R, Rajesh Kannan R. Chrysin-Loaded Chitosan Nanoparticle-
Mediated Neuroprotection in Aβ<sub>1-42</sub>-Induced Neurodegenerative
Conditions in Zebrafish. ACS Chem Neurosci. 2022 Jul 6;13(13):2017-2034. doi:
10.1021/acschemneuro.2c00240. Epub 2022 Jun 13. PMID: 35696319.

27: Zhu R, Jalo E, Silvestre MP, Poppitt SD, Handjieva-Darlenska T, Handjiev S,
Huttunen-Lenz M, Mackintosh K, Stratton G, Navas-Carretero S, Pietiläinen KH,
Simpson E, Macdonald IA, Muirhead R, Brand-Miller J, Fogelholm M, Færch K,
Martinez JA, Westerterp-Plantenga MS, Adam TC, Raben A. Does the Effect of a
3-Year Lifestyle Intervention on Body Weight and Cardiometabolic Health Differ
by Prediabetes Metabolic Phenotype? A Post Hoc Analysis of the PREVIEW Study.
Diabetes Care. 2022 Jun 13:dc220549. doi: 10.2337/dc22-0549. Epub ahead of
print. PMID: 35696263.

28: Teng E, Manser PT, Pickthorn K, Brunstein F, Blendstrup M, Sanabria
Bohorquez S, Wildsmith KR, Toth B, Dolton M, Ramakrishnan V, Bobbala A, Sikkes
SAM, Ward M, Fuji RN, Kerchner GA; Tauriel Investigators. Safety and Efficacy of
Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A
Randomized Clinical Trial. JAMA Neurol. 2022 Aug 1;79(8):758-767. doi:
10.1001/jamaneurol.2022.1375. PMID: 35696185; PMCID: PMC9194753.

29: Dehzangi I, Sharma A, Shatabda S. iProtGly-SS: A Tool to Accurately Predict
Protein Glycation Site Using Structural-Based Features. Methods Mol Biol.
2022;2499:125-134. doi: 10.1007/978-1-0716-2317-6_5. PMID: 35696077.

30: Solimando L, Fasulo M, Cavallero S, Veronese N, Smith L, Vernuccio L,
Bolzetta F, Dominguez LJ, Barbagallo M. Suicide risk in caregivers of people
with dementia: a systematic review and meta-analysis. Aging Clin Exp Res. 2022
Jun 13. doi: 10.1007/s40520-022-02160-6. Epub ahead of print. PMID: 35696056.

31: Morte A, Vaqué A, Iniesta M, Schug B, Koch C, De la Torre R, Schurad B.
Bioavailability Study of a Transdermal Patch Formulation of Rivastigmine
Compared with Exelon in Healthy Subjects. Eur J Drug Metab Pharmacokinet. 2022
Jul;47(4):567-578. doi: 10.1007/s13318-022-00778-5. Epub 2022 Jun 13. PMID:
35696054.

32: Littau JL, Velilla L, Hase Y, Villalba-Moreno ND, Hagel C, Drexler D, Osorio
Restrepo S, Villegas A, Lopera F, Vargas S, Glatzel M, Krasemann S, Quiroz YT,
Arboleda-Velasquez JF, Kalaria R, Sepulveda-Falla D. Evidence of beta amyloid
independent small vessel disease in familial Alzheimer's disease. Brain Pathol.
2022 Jun 13:e13097. doi: 10.1111/bpa.13097. Epub ahead of print. PMID: 35695802.

33: Sari S, Akkaya D, Zengin M, Sabuncuoğlu S, Özdemir Z, Alagöz MA, Karakurt A,
Barut B. Antifungal Azole Derivatives Featuring Naphthalene Prove Potent and
Competitive Cholinesterase Inhibitors with Potential CNS Penetration According
to the in Vitro and in Silico Studies. Chem Biodivers. 2022
Jul;19(7):e202200027. doi: 10.1002/cbdv.202200027. Epub 2022 Jun 23. PMID:
35695705.

34: Hemrungrojn S, Amrapala A, Maes M. Construction of a short version of the
Montreal Cognitive Assessment (MoCA) rating scale for the Thai population using
Partial Least Squares analysis. Int J Neurosci. 2022 Jun 12:1-12. doi:
10.1080/00207454.2022.2082966. Epub ahead of print. PMID: 35695242.

35: Pentecost C, Collins R, Stapley S, Victor C, Quinn C, Hillman A, Litherland
R, Allan L, Clare L. Effects of social restrictions on people with dementia and
carers during the pre-vaccine phase of the COVID-19 pandemic: Experiences of
IDEAL cohort participants. Health Soc Care Community. 2022 Jun
13:10.1111/hsc.13863. doi: 10.1111/hsc.13863. Epub ahead of print. PMID:
35695217; PMCID: PMC9349761.

36: Metkar SK, Girigoswami A, Bondage DD, Shinde UG, Girigoswami K. The
potential of lumbrokinase and serratiopeptidase for the degradation of Aβ 1-42
peptide - an <i>in vitro</i> and <i>in silico</i> approach. Int J Neurosci. 2022
Jun 27:1-12. doi: 10.1080/00207454.2022.2089137. Epub ahead of print. PMID:
35694981.

37: Wang J, Battioui C, McCarthy A, Dang X, Zhang H, Man A, Zou J, Kyle J,
Munsie L, Pugh M, Biglan K. Evaluating the Use of Digital Biomarkers to Test
Treatment Effects on Cognition and Movement in Patients with Lewy Body Dementia.
J Parkinsons Dis. 2022;12(6):1991-2004. doi: 10.3233/JPD-213126. PMID: 35694933.

38: Babiloni C, Noce G, Di Bonaventura C, Lizio R, Eldellaa A, Tucci F, Salamone
EM, Ferri R, Soricelli A, Nobili F, Famà F, Arnaldi D, Palma E, Cifelli P,
Marizzoni M, Stocchi F, Bruno G, Di Gennaro G, Frisoni GB, Del Percio C.
Alzheimer's Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of
Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment.
J Alzheimers Dis. 2022;88(3):903-931. doi: 10.3233/JAD-220442. PMID: 35694930.

39: Duan W, Sehrawat P, Zhou TD, Becker JT, Lopez OL, Gach HM, Dai W. Pattern of
Altered Magnetization Transfer Rate in Alzheimer's Disease. J Alzheimers Dis.
2022;88(2):693-705. doi: 10.3233/JAD-220335. PMID: 35694929; PMCID: PMC9382719.

40: Wessels AM, Belger M, Johnston JA, Yu Y, Rentz DM, Dowsett SA, Chandler J.
Demonstration of Clinical Meaningfulness of the Integrated Alzheimer's Disease
Rating Scale (iADRS): Association Between Change in iADRS Scores and Patient and
Caregiver Health Outcomes. J Alzheimers Dis. 2022;88(2):577-588. doi:
10.3233/JAD-220303. PMID: 35694928; PMCID: PMC9398086.

41: Pyun JM, Park YH, Kim S. Subclinical Hypothyroidism and Cognitive
Impairment. J Alzheimers Dis. 2022;88(2):757-762. doi: 10.3233/JAD-220302. PMID:
35694927.

42: Harper JD, Fan KH, Aslam MM, Snitz BE, DeKosky ST, Lopez OL, Feingold E,
Kamboh MI. Genome-Wide Association Study of Incident Dementia in a Community-
Based Sample of Older Subjects. J Alzheimers Dis. 2022;88(2):787-798. doi:
10.3233/JAD-220293. PMID: 35694926; PMCID: PMC9359180.

43: Sun L, Guo C, Song Y, Sheng J, Xiao S; Alzheimer’s Disease Neuroimaging
Initiative. Blood BMP6 Associated with Cognitive Performance and Alzheimer's
Disease Diagnosis: A Longitudinal Study of Elders. J Alzheimers Dis.
2022;88(2):641-651. doi: 10.3233/JAD-220279. PMID: 35694925.

44: Haehner A, Chen B, Espin M, Haussmann R, Matthes C, Desser D, Loessner L,
Brandt MD, Donix M, Hummel T. Training with Odors Impacts Hippocampal Thickness
in Patients with Mild Cognitive Impairment. J Alzheimers Dis.
2022;88(2):743-755. doi: 10.3233/JAD-220248. PMID: 35694924.

45: Ma X, Zhang Y, Gou D, Ma J, Du J, Wang C, Li S, Cui H. Metabolic
Reprogramming of Microglia Enhances Proinflammatory Cytokine Release through
EphA2/p38 MAPK Pathway in Alzheimer's Disease. J Alzheimers Dis.
2022;88(2):771-785. doi: 10.3233/JAD-220227. PMID: 35694923.

46: Kuriyama N, Koyama T, Ozaki E, Saito S, Ihara M, Matsui D, Watanabe I, Kondo
M, Marunaka Y, Takada A, Akazawa K, Tomida S, Nagamitsu R, Miyatani F, Miyake M,
Nakano E, Kobayashi D, Watanabe Y, Mizuno S, Maekawa M, Yoshida T, Nukaya Y,
Mizuno T, Yamada K, Uehara R. Association Between Cerebral Microbleeds and
Circulating Levels of Mid-Regional Pro-Adrenomedullin. J Alzheimers Dis.
2022;88(2):731-741. doi: 10.3233/JAD-220195. PMID: 35694922.

47: Ramirez-Gomez L, Albers MW, Baena A, Vila-Castelar C, Fox-Fuller JT, Sanchez
J, Jain F, Albers AD, Lopera F, Quiroz YT. Olfactory Function and Markers of
Brain Pathology in Non-Demented Individuals with Autosomal Dominant Alzheimer's
Disease. J Alzheimers Dis. 2022;88(2):721-729. doi: 10.3233/JAD-220075. PMID:
35694921.

48: Schein J, Houle CR, Urganus AL, Jones E, Pike J, Husbands J, Willey CJ. The
Impact of Agitation in Dementia on Caregivers: A Real-World Survey. J Alzheimers
Dis. 2022;88(2):663-677. doi: 10.3233/JAD-215670. PMID: 35694920; PMCID:
PMC9398061.

49: García-Alberca JM, Gris E, de la Guía P, Mendoza S. Effects of Tianeptine
Treatment on Depression and Cognitive Function in Patients with Alzheimer's
Disease: A 12-Month Retrospective Observational Study. J Alzheimers Dis.
2022;88(2):707-720. doi: 10.3233/JAD-215630. PMID: 35694919; PMCID: PMC9398087.

50: Agarwal P, Holland TM, James BD, Cherian LJ, Aggarwal NT, Leurgans SE,
Bennett DA, Schneider JA. Pelargonidin and Berry Intake Association with
Alzheimer's Disease Neuropathology: A Community-Based Study. J Alzheimers Dis.
2022;88(2):653-661. doi: 10.3233/JAD-215600. PMID: 35694918.

51: Sahoo BR, Bardwell JCA. SERF, a family of tiny highly conserved, highly
charged proteins with enigmatic functions. FEBS J. 2022 Jun 13. doi:
10.1111/febs.16555. Epub ahead of print. PMID: 35694898.

52: Park JC, Barahona-Torres N, Jang SY, Mok KY, Kim HJ, Han SH, Cho KH, Zhou X,
Fu AKY, Ip NY, Seo J, Choi M, Jeong H, Hwang D, Lee DY, Byun MS, Yi D, Han JW,
Mook-Jung I, Hardy J. Multi-Omics-Based Autophagy-Related Untypical Subtypes in
Patients with Cerebral Amyloid Pathology. Adv Sci (Weinh). 2022
Aug;9(23):e2201212. doi: 10.1002/advs.202201212. Epub 2022 Jun 13. PMID:
35694866; PMCID: PMC9376815.

53: Chen MS, Chen WR, Ho HH, Lin SC. Effect of stimuli type on affective memory
of patients with different severities of cognitive impairment. Aging Ment
Health. 2022 Jun 11:1-7. doi: 10.1080/13607863.2022.2087211. Epub ahead of
print. PMID: 35694857.

54: Lv H, Wang Y, Yang X, Ling G, Zhang P. Application of curcumin
nanoformulations in Alzheimer's disease: prevention, diagnosis and treatment.
Nutr Neurosci. 2022 Jun 11:1-16. doi: 10.1080/1028415X.2022.2084550. Epub ahead
of print. PMID: 35694842.

55: Hammond BR, Renzi-Hammond L. The influence of the macular carotenoids on
women's eye and brain health. Nutr Neurosci. 2022 Jun 11:1-7. doi:
10.1080/1028415X.2022.2084125. Epub ahead of print. PMID: 35694839.

56: Pathak A, Roy D, Banerjee A. Whole-Brain Network Models: From Physics to
Bedside. Front Comput Neurosci. 2022 May 26;16:866517. doi:
10.3389/fncom.2022.866517. PMID: 35694610; PMCID: PMC9180729.

57: Cui Y, Yu H, Bu Z, Wen L, Yan L, Feng J. Focus on the Role of the NLRP3
Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics.
Front Mol Neurosci. 2022 May 25;15:894298. doi: 10.3389/fnmol.2022.894298. PMID:
35694441; PMCID: PMC9175009.

58: Dai Z, Hu T, Su S, Liu J, Ma Y, Zhuo Y, Fang S, Wang Q, Mo Z, Pan H, Fang J.
Comparative Metabolomics Analysis Reveals Key Metabolic Mechanisms and Protein
Biomarkers in Alzheimer's Disease. Front Pharmacol. 2022 May 25;13:904857. doi:
10.3389/fphar.2022.904857. PMID: 35694256; PMCID: PMC9174950.

59: Scarlett JM, Hu SJ, Alonge KM. The "Loss" of Perineuronal Nets in
Alzheimer's Disease: Missing or Hiding in Plain Sight? Front Integr Neurosci.
2022 May 25;16:896400. doi: 10.3389/fnint.2022.896400. PMID: 35694184; PMCID:
PMC9174696.

60: Neal J, Hutchings PB, Phelps C, Williams D. Football and Dementia:
Understanding the Link. Front Psychiatry. 2022 May 27;13:849876. doi:
10.3389/fpsyt.2022.849876. PMID: 35693952; PMCID: PMC9184440.

61: Jauny G, Eustache F, Hinault TT. M/EEG Dynamics Underlying Reserve,
Resilience, and Maintenance in Aging: A Review. Front Psychol. 2022 May
25;13:861973. doi: 10.3389/fpsyg.2022.861973. PMID: 35693495; PMCID: PMC9174693.

62: Wang L, Jiao Y, Zhao A, Xu X, Ye G, Zhang Y, Wang Y, Deng Y, Xu W, Liu J.
Analysis of Genetic Association Between <i>ABCA7</i> Polymorphism and
Alzheimer's Disease Risk in the Southern Chinese Population. Front Aging
Neurosci. 2022 May 25;14:819499. doi: 10.3389/fnagi.2022.819499. PMID: 35693347;
PMCID: PMC9175022.

63: Lu J, Zeng W, Zhang L, Shi Y. A Novel Key Features Screening Method Based on
Extreme Learning Machine for Alzheimer's Disease Study. Front Aging Neurosci.
2022 May 25;14:888575. doi: 10.3389/fnagi.2022.888575. PMID: 35693342; PMCID:
PMC9177228.

64: Xu YJ, Au NPB, Ma CHE. Functional and Phenotypic Diversity of Microglia:
Implication for Microglia-Based Therapies for Alzheimer's Disease. Front Aging
Neurosci. 2022 May 26;14:896852. doi: 10.3389/fnagi.2022.896852. PMID: 35693341;
PMCID: PMC9178186.

65: Teitsdottir UD, Darreh-Shori T, Lund SH, Jonsdottir MK, Snaedal J, Petersen
PH. Phenotypic Displays of Cholinergic Enzymes Associate With Markers of
Inflammation, Neurofibrillary Tangles, and Neurodegeneration in Pre- and Early
Symptomatic Dementia Subjects. Front Aging Neurosci. 2022 May 26;14:876019. doi:
10.3389/fnagi.2022.876019. PMID: 35693340; PMCID: PMC9178195.

66: Liu R, Li G, Gao M, Cai W, Ning X. Large Margin and Local Structure
Preservation Sparse Representation Classifier for Alzheimer's Magnetic Resonance
Imaging Classification. Front Aging Neurosci. 2022 May 25;14:916020. doi:
10.3389/fnagi.2022.916020. PMID: 35693338; PMCID: PMC9177229.

67: Song Y, Wu H, Chen S, Ge H, Yan Z, Xue C, Qi W, Yuan Q, Liang X, Lin X, Chen
J. Differential Abnormality in Functional Connectivity Density in Preclinical
and Early-Stage Alzheimer's Disease. Front Aging Neurosci. 2022 May
25;14:879836. doi: 10.3389/fnagi.2022.879836. PMID: 35693335; PMCID: PMC9177137.

68: Faraji N, Salehi I, Alizadeh A, Pourgholaminejad A, Komaki A, Azandaryani
MT, Sadeghian R, Golipoor Z. Comparing the Effects of Long-term Exposure to
Extremely Low-frequency Electromagnetic Fields With Different Values on
Learning, Memory, Anxiety, and β-amyloid Deposition in Adult Rats. Basic Clin
Neurosci. 2021 Nov-Dec;12(6):849-860. doi: 10.32598/bcn.2021.1204.2. Epub 2021
Nov 1. PMID: 35693151; PMCID: PMC9168822.

69: Nasiri M, Kaeidi A, Fatemi I, Azin M, Bannazadeh M, Allahtavakoli M,
Roohbakhsh A, Shamsizadeh A. Modulatory Effects of Memantine on Neuronal
Response Properties in Rat Barrel Cortex. Basic Clin Neurosci. 2021 Nov-
Dec;12(6):721-728. doi: 10.32598/bcn.2021.1156.2. Epub 2021 Nov 1. PMID:
35693139; PMCID: PMC9168817.

70: Sumsuzzman DM, Uddin MS, Kabir MT, Hasana S, Perveen A, Alanazi IS,
Albadrani GM, Abdel-Daim MM, Ashraf GM. Microglia in Alzheimer's Disease: A
Favorable Cellular Target to Ameliorate Alzheimer's Pathogenesis. Mediators
Inflamm. 2022 Jun 2;2022:6052932. doi: 10.1155/2022/6052932. PMID: 35693110;
PMCID: PMC9184163.

71: Dorcet G, Benaiteau M, Ory-Magne F, Blancher A, Pariente J, Fortenfant F,
Bost C. Case Report: Presence of Anti-MAG in the CSF Can Be Associated With a
Neurodegenerative Process With Frontal Involvement. Front Neurol. 2022 May
25;13:847798. doi: 10.3389/fneur.2022.847798. PMID: 35693016; PMCID: PMC9176167.

72: Ellison JM, Husain-Krautter S. Disclosure of a Dementia Diagnosis::
Minimizing Medical Trauma. Dela J Public Health. 2022 May 31;8(2):76-77. doi:
10.32481/djph.2022.05.009. PMID: 35692987; PMCID: PMC9162401.

73: Koebele SV, Poisson ML, Palmer JM, Berns-Leone C, Northup-Smith SN, Peña VL,
Strouse IM, Bulen HL, Patel S, Croft C, Bimonte-Nelson HA. Evaluating the
Cognitive Impacts of Drospirenone, a Spironolactone-Derived Progestin,
Independently and in Combination With Ethinyl Estradiol in Ovariectomized Adult
Rats. Front Neurosci. 2022 May 25;16:885321. doi: 10.3389/fnins.2022.885321.
PMID: 35692432; PMCID: PMC9177129.

74: Peppercorn K, Kleffmann T, Jones O, Hughes S, Tate W. Secreted Amyloid
Precursor Protein Alpha, a Neuroprotective Protein in the Brain Has Widespread
Effects on the Transcriptome and Proteome of Human Inducible Pluripotent Stem
Cell-Derived Glutamatergic Neurons Related to Memory Mechanisms. Front Neurosci.
2022 May 26;16:858524. doi: 10.3389/fnins.2022.858524. PMID: 35692428; PMCID:
PMC9179159.

75: Xue B, Waseem SMA, Zhu Z, Alshahrani MA, Nazam N, Anjum F, Habib AH, Rafeeq
MM, Nazam F, Sharma M. Brain-Derived Neurotrophic Factor: A Connecting Link
Between Nutrition, Lifestyle, and Alzheimer's Disease. Front Neurosci. 2022 May
25;16:925991. doi: 10.3389/fnins.2022.925991. PMID: 35692417; PMCID: PMC9177140.

76: Yuan F, Sadovnik A, Zhang R, Casenhiser D, Paek EJ, Zhao X. A simulated
experiment to explore robotic dialogue strategies for people with dementia. J
Rehabil Assist Technol Eng. 2022 Jun 5;9:20556683221105768. doi:
10.1177/20556683221105768. PMID: 35692231; PMCID: PMC9174559.

77: Kesharwani P, Kumari K, Gururani R, Jain S, Sharma S. Approaches to Address
PK-PD Challenges of Conventional Liposome Formulation with Special Reference to
Cancer, Alzheimer's, Diabetes, and Glaucoma: An Update on Modified Liposomal
Drug Delivery System. Curr Drug Metab. 2022 Jun 9. doi:
10.2174/1389200223666220609141459. Epub ahead of print. PMID: 35692131.

78: Khandia R, Viswanathan N, Singhal S, Alqahtani T, A Almikhlafi M,
Nikolaevich Simonov A, Md Ashraf G. Ameliorative effects of phytomedicines on
Alzheimer's patients. Curr Alzheimer Res. 2022 Jun 10. doi:
10.2174/1567205019666220610155608. Epub ahead of print. PMID: 35692129.

79: Huang S, Zhang Z, Cao J, Yu Y, Pei G. Chimeric cerebral organoids reveal the
essentials of neuronal and astrocytic APOE4 for Alzheimer's tau pathology.
Signal Transduct Target Ther. 2022 Jun 13;7(1):176. doi:
10.1038/s41392-022-01006-x. PMID: 35691989; PMCID: PMC9189105.

80: Kajikawa T, Mastellos DC, Hasturk H, Kotsakis GA, Yancopoulou D, Lambris JD,
Hajishengallis G. C3-targeted host-modulation approaches to oral inflammatory
conditions. Semin Immunol. 2022 Jun 9:101608. doi: 10.1016/j.smim.2022.101608.
Epub ahead of print. PMID: 35691883.

81: Mangalmurti A, Lukens JR. How neurons die in Alzheimer's disease:
Implications for neuroinflammation. Curr Opin Neurobiol. 2022 Aug;75:102575.
doi: 10.1016/j.conb.2022.102575. Epub 2022 Jun 10. PMID: 35691251; PMCID:
PMC9380082.

82: Jellinger KA. Are there morphological differences between Parkinson's
disease-dementia and dementia with Lewy bodies? Parkinsonism Relat Disord. 2022
Jul;100:24-32. doi: 10.1016/j.parkreldis.2022.05.024. Epub 2022 Jun 3. PMID:
35691178.

83: Guan L, Mao Z, Yang S, Wu G, Chen Y, Yin L, Qi Y, Han L, Xu L. Dioscin
alleviates Alzheimer's disease through regulating RAGE/NOX4 mediated oxidative
stress and inflammation. Biomed Pharmacother. 2022 Aug;152:113248. doi:
10.1016/j.biopha.2022.113248. Epub 2022 Jun 10. PMID: 35691153.

84: Ma X, Liu L, Meng J. Retraction notice to "MicroRNA-125b promotes neurons
cell apoptosis and tau phosphorylation in Alzheimer's disease" [Neurosci. Lett.
661 (2017) 57-62]. Neurosci Lett. 2022 Jul 13;783:136703. doi:
10.1016/j.neulet.2022.136703. Epub 2022 Jun 9. PMID: 35691149.

85: Singh NA, Tosakulwong N, Graff-Radford J, Machulda MM, Pham NTT, Sintini I,
Weigand SD, Schwarz CG, Senjem ML, Carrasquillo MM, Ertekin-Taner N, Jack CR
 Jr, Lowe VJ, Josephs KA, Whitwell JL. APOE ε4 influences medial temporal
atrophy and tau deposition in atypical Alzheimer's disease. Alzheimers Dement.
2022 Jun 12. doi: 10.1002/alz.12711. Epub ahead of print. PMID: 35691047.

86: Leduc-Gaudet JP, Hussain SN, Gouspillou G. Parkin: a potential target to
promote healthy ageing. J Physiol. 2022 Aug;600(15):3405-3421. doi:
10.1113/JP282567. Epub 2022 Jul 9. PMID: 35691026.

87: Ashraf MA, Goyal A. Fludeoxyglucose (18F). 2022 Jun 13. In: StatPearls
[Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID:
32491585.

88: Xia D, Lianoglou S, Sandmann T, Calvert M, Suh JH, Thomsen E, Dugas J, Pizzo
ME, DeVos SL, Earr TK, Lin CC, Davis S, Ha C, Leung AW, Nguyen H, Chau R,
Yulyaningsih E, Lopez I, Solanoy H, Masoud ST, Liang CC, Lin K, Astarita G,
Khoury N, Zuchero JY, Thorne RG, Shen K, Miller S, Palop JJ, Garceau D, Sasner
M, Whitesell JD, Harris JA, Hummel S, Gnörich J, Wind K, Kunze L, Zatcepin A,
Brendel M, Willem M, Haass C, Barnett D, Zimmer TS, Orr AG, Scearce-Levie K,
Lewcock JW, Di Paolo G, Sanchez PE. Novel App knock-in mouse model shows key
features of amyloid pathology and reveals profound metabolic dysregulation of
microglia. Mol Neurodegener. 2022 Jun 11;17(1):41. doi:
10.1186/s13024-022-00547-7. PMID: 35690868; PMCID: PMC9188195.

89: Wirth M, Schwarz C, Benson G, Horn N, Buchert R, Lange C, Köbe T, Hetzer S,
Maglione M, Michael E, Märschenz S, Mai K, Kopp U, Schmitz D, Grittner U,
Sigrist SJ, Stekovic S, Madeo F, Flöel A. Correction: Effects of spermidine
supplementation on cognition and biomarkers in older adults with subjective
cognitive decline (SmartAge)-study protocol for a randomized controlled trial.
Alzheimers Res Ther. 2022 Jun 11;14(1):81. doi: 10.1186/s13195-022-01012-9.
Erratum for: Alzheimers Res Ther. 2019 May 1;11(1):36. PMID: 35690844; PMCID:
PMC9188143.

90: Griffiths J, Grant SGN. Synapse pathology in Alzheimer's disease. Semin Cell
Dev Biol. 2022 Jun 8:S1084-9521(22)00186-0. doi: 10.1016/j.semcdb.2022.05.028.
Epub ahead of print. PMID: 35690535.

91: Prasad S, Katta MR, Abhishek S, Sridhar R, Valisekka SS, Hameed M, Kaur J,
Walia N. Recent advances in Lewy body dementia: A comprehensive review. Dis Mon.
2022 Jun 8:101441. doi: 10.1016/j.disamonth.2022.101441. Epub ahead of print.
PMID: 35690493.

92: eBioMedicine. Biomarkers for Alzheimer's disease: Earlier, easier, and
fairer. EBioMedicine. 2022 Jun;80:104114. doi: 10.1016/j.ebiom.2022.104114.
PMID: 35690396; PMCID: PMC9194949.

93: Wu Y, Wu X, Gao L, Yan Y, Geng Z, Zhou S, Zhu W, Tian Y, Yu Y, Wei L, Wang
K. Abnormal Functional Connectivity of Thalamic Subdivisions in Alzheimer's
Disease: A Functional Magnetic Resonance Imaging Study. Neuroscience. 2022 Aug
1;496:73-82. doi: 10.1016/j.neuroscience.2022.06.006. Epub 2022 Jun 8. PMID:
35690336.

94: Quintino L, Gubinelli F, Sarauskyte L, Arvidsson E, Davidsson M, Lundberg C,
Heuer A. Automated quantification of neuronal swellings in a preclinical rodent
model of Parkinson's disease detects region-specific changes in pathology. J
Neurosci Methods. 2022 Aug 1;378:109640. doi: 10.1016/j.jneumeth.2022.109640.
Epub 2022 Jun 8. PMID: 35690332.

95: Cogswell PM, Aakre JA, Castillo AM, Knopman DS, Kantarci K, Rabinstein AA,
Petersen RC, Jack CR Jr, Mielke MM, Vemuri P, Graff-Radford J. Population-Based
Prevalence of Infarctions on 3D Fluid-Attenuated Inversion Recovery (FLAIR)
Imaging. J Stroke Cerebrovasc Dis. 2022 Aug;31(8):106583. doi:
10.1016/j.jstrokecerebrovasdis.2022.106583. Epub 2022 Jun 8. PMID: 35689933;
PMCID: PMC9329259.

96: Werner NE, Rutkowski RA, Holden RJ, Ponnala S, Gilmore-Bykovskyi A. A human
factors and ergonomics approach to conceptualizing care work among caregivers of
people with dementia. Appl Ergon. 2022 Oct;104:103820. doi:
10.1016/j.apergo.2022.103820. Epub 2022 Jun 8. PMID: 35689868; PMCID:
PMC9392469.

97: Zhang X, Lei T, Wang D, Cai S, Hang Z, Yang Y, Bi W, Xiao Z, Du H. Stem
cells from human exfoliated deciduous teeth relieves Alzheimer's disease
symptoms in SAMP8 mice by up-regulating the PPARγ pathway. Biomed Pharmacother.
2022 Aug;152:113169. doi: 10.1016/j.biopha.2022.113169. Epub 2022 Jun 9. PMID:
35689863.

98: Crivelli SM, Luo Q, Kruining DV, Giovagnoni C, Mané-Damas M, den Hoedt S,
Berkes D, De Vries HE, Mulder MT, Walter J, Waelkens E, Derua R, Swinnen JV,
Dehairs J, Wijnands EPM, Bieberich E, Losen M, Martinez-Martinez P. FTY720
decreases ceramides levels in the brain and prevents memory impairments in a
mouse model of familial Alzheimer's disease expressing APOE4. Biomed
Pharmacother. 2022 Aug;152:113240. doi: 10.1016/j.biopha.2022.113240. Epub 2022
Jun 9. PMID: 35689862.

99: Liu J, Liu L, Zheng L, Feng KW, Wang HT, Xu JP, Zhou ZZ. Discovery of novel
2,3-dihydro-1H-inden-1-ones as dual PDE4/AChE inhibitors with more potency
against neuroinflammation for the treatment of Alzheimer's disease. Eur J Med
Chem. 2022 Aug 5;238:114503. doi: 10.1016/j.ejmech.2022.114503. Epub 2022 Jun 3.
PMID: 35689855.

100: Goldman JE. Alzheimer Type I Astrocytes: Still Mysterious Cells. J
Neuropathol Exp Neurol. 2022 Jul 19;81(8):588-595. doi: 10.1093/jnen/nlac043.
PMID: 35689655.

101: Schindler SE, Ney DE, Goss AL, Rabinovici G. ANA Investigates: The Future
of Biomarkers in Alzheimer Disease. Ann Neurol. 2022 Aug;92(2):159-160. doi:
10.1002/ana.26437. Epub 2022 Jun 30. PMID: 35689567.

102: Taati Moghadam M, Amirmozafari N, Mojtahedi A, Bakhshayesh B, Shariati A,
Masjedian Jazi F. Association of perturbation of oral bacterial with incident of
Alzheimer's disease: A pilot study. J Clin Lab Anal. 2022 Jul;36(7):e24483. doi:
10.1002/jcla.24483. Epub 2022 Jun 11. PMID: 35689551; PMCID: PMC9279996.

103: Sobhani A, Sharifi F, Fadayevatan R, Kamrani AAA, Moodi M, Khorashadizadeh
M, Kazemi T, Khodabakhshi H, Fakhrzadeh H, Arzaghi M, Badrkhahan SZ, Hosseini
RS, Monji H, Nikkhah A. Low physical activity is the strongest factor associated
with frailty phenotype and frailty index: data from baseline phase of Birjand
Longitudinal Aging Study (BLAS). BMC Geriatr. 2022 Jun 10;22(1):498. doi:
10.1186/s12877-022-03135-y. PMID: 35689187; PMCID: PMC9188172.

104: Wereszczyński M, Niedźwieńska A. Deficits in spontaneous and stimulus-
dependent retrieval as an early sign of abnormal aging. Sci Rep. 2022 Jun
10;12(1):9643. doi: 10.1038/s41598-022-13745-6. PMID: 35688927; PMCID:
PMC9187621.

105: Jhanji M, Rao CN, Massey JC, Hope MC 3rd, Zhou X, Keene CD, Ma T, Wyatt MD,
Stewart JA, Sajish M. Cis- and trans-resveratrol have opposite effects on
histone serine-ADP-ribosylation and tyrosine induced neurodegeneration. Nat
Commun. 2022 Jun 10;13(1):3244. doi: 10.1038/s41467-022-30785-8. PMID: 35688816;
PMCID: PMC9187644.

106: Hu H, Du W, Zhang W, Fang J. Cirsiliol mitigates Aβ fibrillation and
underlying membrane-leakage associated neurotoxicity: A possible implication in
the treatment of neurodegenerative disease. Int J Biol Macromol. 2022 Jul
31;213:915-922. doi: 10.1016/j.ijbiomac.2022.06.023. Epub 2022 Jun 8. PMID:
35688279.

107: Sanderson JM. The association of lipids with amyloid fibrils. J Biol Chem.
2022 Aug;298(8):102108. doi: 10.1016/j.jbc.2022.102108. Epub 2022 Jun 8. PMID:
35688209; PMCID: PMC9293637.

108: Pal T, Paul R, Paul S. Phenylpropanoids on the Inhibition of β-Amyloid
Aggregation and the Movement of These Molecules through the POPC Lipid Bilayer.
Langmuir. 2022 Jun 28;38(25):7775-7790. doi: 10.1021/acs.langmuir.2c00827. Epub
2022 Jun 10. PMID: 35687701.

109: Thomas J, Martinez-Reza MF, Thorwirth M, Zarb Y, Conzelmann KK, Hauck SM,
Grade S, Götz M. Excessive local host-graft connectivity in aging and amyloid-
loaded brain. Sci Adv. 2022 Jun 10;8(23):eabg9287. doi: 10.1126/sciadv.abg9287.
Epub 2022 Jun 10. PMID: 35687689; PMCID: PMC9187230.

110: Qneibi M, Hawash M, Jaradat N, Bdir S. Affecting AMPA Receptor Biophysical
Gating Properties with Negative Allosteric Modulators. Mol Neurobiol. 2022
Sep;59(9):5264-5275. doi: 10.1007/s12035-022-02913-4. Epub 2022 Jun 10. PMID:
35687302; PMCID: PMC9186005.

111: Iyer RR, Renteria CA, Yang L, Sorrells JE, Park J, Sun L, Yu Z, Huang Y,
Marjanovic M, Mirica LM, Boppart SA. Tracking the binding of multi-functional
fluorescent tags for Alzheimer's disease using quantitative multiphoton
microscopy. J Biophotonics. 2022 Sep;15(9):e202200105. doi:
10.1002/jbio.202200105. Epub 2022 Jun 24. PMID: 35686672.

112: Vasdev N, Handa M, Kesharwani P, Shukla R. Rosemary oil low energy
nanoemulsion: optimization, µrheology, <i>in silico, in vitro, and ex vivo</i>
characterization. J Biomater Sci Polym Ed. 2022 Jun 23:1-23. doi:
10.1080/09205063.2022.2088527. Epub ahead of print. PMID: 35686513.

113: Barracchia CG, Parolini F, Volpe A, Gori D, Munari F, Capaldi S, D'Onofrio
M, Assfalg M. Camouflaged Fluorescent Silica Nanoparticles Target Aggregates and
Condensates of the Amyloidogenic Protein Tau. Bioconjug Chem. 2022 Jul
20;33(7):1261-1268. doi: 10.1021/acs.bioconjchem.2c00168. Epub 2022 Jun 10.
PMID: 35686491; PMCID: PMC9305972.

114: Kocatürk RR, Temizyürek A, Özcan ÖÖ, Ergüzel TT, Karahan M, Konuk M, Tarhan
N. Effect of nutritional supports on malnutrition, cognition, function and
biomarkers of Alzheimer's disease: a systematic review. Int J Neurosci. 2022 Jul
3:1-19. doi: 10.1080/00207454.2022.2079506. Epub ahead of print. PMID: 35686376.

115: Watanabe H, Hikida S, Ikeda M, Mori E. Unclassified fluent variants of
primary progressive aphasia: distinction from semantic and logopenic variants.
Brain Commun. 2022 Feb 2;4(3):fcac015. doi: 10.1093/braincomms/fcac015. PMID:
35686225; PMCID: PMC9171501.

116: Bellanti F, Bukke VN, Moola A, Villani R, Scuderi C, Steardo L, Palombelli
G, Canese R, Beggiato S, Altamura M, Vendemiale G, Serviddio G, Cassano T.
Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics,
Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a
Triple Transgenic Mouse Model of Alzheimer's Disease. Front Aging Neurosci. 2022
May 24;14:890855. doi: 10.3389/fnagi.2022.890855. PMID: 35686025; PMCID:
PMC9170916.

117: Wang Z, Ren K, Li D, Lv Z, Li X, He X, Wang D, Jiang W. Assessment of Brain
Function in Patients With Cognitive Impairment Based on fNIRS and Gait Analysis.
Front Aging Neurosci. 2022 May 24;14:799732. doi: 10.3389/fnagi.2022.799732.
PMID: 35686022; PMCID: PMC9170988.

118: Yao L, Zhou Z, Wang S, Zou Q, Wang HX, Ma LX, Wang S, Zhang X.
Phosphorylation of covalent organic framework nanospheres for inhibition of
amyloid-β peptide fibrillation. Chem Sci. 2022 Apr 22;13(20):5902-5912. doi:
10.1039/d2sc00253a. PMID: 35685783; PMCID: PMC9132083.

119: Webberley TS, Masetti G, Bevan RJ, Kerry-Smith J, Jack AA, Michael DR,
Thomas S, Glymenaki M, Li J, McDonald JAK, John D, Morgan JE, Marchesi JR, Good
MA, Plummer SF, Hughes TR. The Impact of Probiotic Supplementation on Cognitive,
Pathological and Metabolic Markers in a Transgenic Mouse Model of Alzheimer's
Disease. Front Neurosci. 2022 May 24;16:843105. doi: 10.3389/fnins.2022.843105.
PMID: 35685773; PMCID: PMC9172594.

120: Chen B, Marquez-Nostra B, Belitzky E, Toyonaga T, Tong J, Huang Y, Cai Z.
PET Imaging in Animal Models of Alzheimer's Disease. Front Neurosci. 2022 May
24;16:872509. doi: 10.3389/fnins.2022.872509. PMID: 35685772; PMCID: PMC9171374.

121: Andersen N, Veuthey T, Blanco MG, Silbestri GF, Rayes D, De Rosa MJ.
1-Mesityl-3-(3-Sulfonatopropyl) Imidazolium Protects Against Oxidative Stress
and Delays Proteotoxicity in <i>C. elegans</i>. Front Pharmacol. 2022 May
24;13:908696. doi: 10.3389/fphar.2022.908696. PMID: 35685626; PMCID: PMC9171001.

122: Jimenez Chavez CL, Van Doren E, Matalon J, Ogele N, Kharwa A, Madory L,
Kazerani I, Herbert J, Torres-Gonzalez J, Rivera E, Szumlinski KK. Alcohol-
Drinking Under Limited-Access Procedures During Mature Adulthood Accelerates the
Onset of Cognitive Impairment in Mice. Front Behav Neurosci. 2022 May
24;16:732375. doi: 10.3389/fnbeh.2022.732375. PMID: 35685271; PMCID: PMC9171112.

123: Smith LA, Goodman AM, McMahon LL. Dentate Granule Cells Are Hyperexcitable
in the TgF344-AD Rat Model of Alzheimer's Disease. Front Synaptic Neurosci. 2022
May 24;14:826601. doi: 10.3389/fnsyn.2022.826601. PMID: 35685246; PMCID:
PMC9171068.

124: Zhang CY, Deng YM, Li DM, Shi QY, Yang XP, Zhao YH, Yang B, Song LG, Li X.
Reliability and Validity of the Repeatable Battery for Assessment of
Neuropsychological Status Scale in Evaluation of Vascular Cognitive Impairment
in Elderly Han Population. Noro Psikiyatr Ars. 2022 Apr 29;59(2):147-150. doi:
10.29399/npa.27854. PMID: 35685057; PMCID: PMC9142023.

125: Stolp Andersen M, Tan M, Holtman IR, Hardy J; International Parkinson's
Disease Genomics Consortium, Pihlstrøm L. Dissecting the limited genetic overlap
of Parkinson's and Alzheimer's disease. Ann Clin Transl Neurol. 2022
Aug;9(8):1289-1295. doi: 10.1002/acn3.51606. Epub 2022 Jun 9. PMID: 35684951;
PMCID: PMC9380131.

126: Baghdadi NA, Malki A, Balaha HM, Badawy M, Elhosseini M. A<sup>3</sup>C-TL-
GTO: Alzheimer Automatic Accurate Classification Using Transfer Learning and
Artificial Gorilla Troops Optimizer. Sensors (Basel). 2022 Jun 2;22(11):4250.
doi: 10.3390/s22114250. PMID: 35684871; PMCID: PMC9185328.

127: De Falco I, De Pietro G, Sannino G. A Two-Step Approach for Classification
in Alzheimer's Disease. Sensors (Basel). 2022 May 24;22(11):3966. doi:
10.3390/s22113966. PMID: 35684587; PMCID: PMC9183018.

128: Gxaba N, Manganyi MC. The Fight against Infection and Pain: Devil's Claw
(<i>Harpagophytum procumbens</i>) a Rich Source of Anti-Inflammatory Activity:
2011-2022. Molecules. 2022 Jun 6;27(11):3637. doi: 10.3390/molecules27113637.
PMID: 35684573; PMCID: PMC9182060.

129: Hou T, Netala VR, Zhang H, Xing Y, Li H, Zhang Z. <i>Perilla
frutescens</i>: A Rich Source of Pharmacological Active Compounds. Molecules.
2022 Jun 2;27(11):3578. doi: 10.3390/molecules27113578. PMID: 35684514; PMCID:
PMC9182122.

130: McGraw C, Koretz KS, Oseid D, Lyman E, Robinson AS. Cholesterol Dependent
Activity of the Adenosine A<sub>2A</sub> Receptor Is Modulated via the
Cholesterol Consensus Motif. Molecules. 2022 May 31;27(11):3529. doi:
10.3390/molecules27113529. PMID: 35684466; PMCID: PMC9182133.

131: Zehravi M, Kabir J, Akter R, Malik S, Ashraf GM, Tagde P, Ramproshad S,
Mondal B, Rahman MH, Mohan AG, Cavalu S. A Prospective Viewpoint on Neurological
Diseases and Their Biomarkers. Molecules. 2022 May 30;27(11):3516. doi:
10.3390/molecules27113516. PMID: 35684455; PMCID: PMC9182418.

132: Nandwana V, Nandwana NK, Das Y, Saito M, Panda T, Das S, Almaguel F,
Hosmane NS, Das BC. The Role of Microbiome in Brain Development and
Neurodegenerative Diseases. Molecules. 2022 May 25;27(11):3402. doi:
10.3390/molecules27113402. PMID: 35684340; PMCID: PMC9182002.

133: Rojas-González A, Figueroa-Hernández CY, González-Rios O, Suárez-Quiroz ML,
González-Amaro RM, Hernández-Estrada ZJ, Rayas-Duarte P. Coffee Chlorogenic
Acids Incorporation for Bioactivity Enhancement of Foods: A Review. Molecules.
2022 May 25;27(11):3400. doi: 10.3390/molecules27113400. PMID: 35684338; PMCID:
PMC9181911.

134: Khalid A, Abdalla M, Saeed M, Ghayur MN, Kalauni SK, Albratty M, Alhazmi
HA, Mesaik MA, Gilani AH, Ul-Haq Z. Sarcorucinine-D Inhibits Cholinesterases and
Calcium Channels: Molecular Dynamics Simulation and In Vitro Mechanistic
Investigations. Molecules. 2022 May 24;27(11):3361. doi:
10.3390/molecules27113361. PMID: 35684298; PMCID: PMC9182202.

135: Amir Rawa MS, Mazlan MKN, Ahmad R, Nogawa T, Wahab HA. Roles of
<i>Syzygium</i> in Anti-Cholinesterase, Anti-Diabetic, Anti-Inflammatory, and
Antioxidant: From Alzheimer's Perspective. Plants (Basel). 2022 May
31;11(11):1476. doi: 10.3390/plants11111476. PMID: 35684249; PMCID: PMC9183156.

136: Drouka A, Mamalaki E, Karavasilis E, Scarmeas N, Yannakoulia M. Dietary and
Nutrient Patterns and Brain MRI Biomarkers in Dementia-Free Adults. Nutrients.
2022 Jun 3;14(11):2345. doi: 10.3390/nu14112345. PMID: 35684145; PMCID:
PMC9183163.

137: Lai MC, Liu WY, Liou SS, Liu IM. Diosmetin Targeted at Peroxisome
Proliferator-Activated Receptor Gamma Alleviates Advanced Glycation End Products
Induced Neuronal Injury. Nutrients. 2022 May 27;14(11):2248. doi:
10.3390/nu14112248. PMID: 35684047; PMCID: PMC9183070.

138: Evans JA, Mendonca P, Soliman KFA. Neuroprotective Effects and Therapeutic
Potential of the Citrus Flavonoid Hesperetin in Neurodegenerative Diseases.
Nutrients. 2022 May 26;14(11):2228. doi: 10.3390/nu14112228. PMID: 35684025;
PMCID: PMC9183194.

139: Rosell-Cardona C, Amat C, Griñán-Ferré C, Polo J, Pallàs M, Pérez-Bosque A,
Moretó M, Miró L. The Neuroprotective Effects of Spray-Dried Porcine Plasma
Supplementation Involve the Microbiota-Gut-Brain Axis. Nutrients. 2022 May
26;14(11):2211. doi: 10.3390/nu14112211. PMID: 35684013; PMCID: PMC9183112.

140: López-Cuenca I, Salobrar-García E, Sánchez-Puebla L, Espejel E, García Del
Arco L, Rojas P, Elvira-Hurtado L, Fernández-Albarral JA, Ramírez-Toraño F,
Barabash A, Salazar JJ, Ramírez JM, de Hoz R, Ramírez AI. Retinal Vascular Study
Using OCTA in Subjects at High Genetic Risk of Developing Alzheimer's Disease
and Cardiovascular Risk Factors. J Clin Med. 2022 Jun 6;11(11):3248. doi:
10.3390/jcm11113248. PMID: 35683633; PMCID: PMC9181641.

141: Agnello L, Lo Sasso B, Vidali M, Scazzone C, Gambino CM, Piccoli T, Bivona
G, Ciaccio AM, Giglio RV, La Bella V, Ciaccio M. Evaluation of Alpha-Synuclein
Cerebrospinal Fluid Levels in Several Neurological Disorders. J Clin Med. 2022
May 31;11(11):3139. doi: 10.3390/jcm11113139. PMID: 35683523; PMCID: PMC9181117.

142: Romanescu C, Schreiner TG, Mukovozov I. The Role of Human Herpesvirus 6
Infection in Alzheimer's Disease Pathogenicity-A Theoretical Mosaic. J Clin Med.
2022 May 29;11(11):3061. doi: 10.3390/jcm11113061. PMID: 35683449; PMCID:
PMC9181317.

143: Zhao X, Huang X, Yang C, Jiang Y, Zhou W, Zheng W. Artemisinin Attenuates
Amyloid-Induced Brain Inflammation and Memory Impairments by Modulating TLR4/NF-
κB Signaling. Int J Mol Sci. 2022 Jun 6;23(11):6354. doi: 10.3390/ijms23116354.
PMID: 35683033; PMCID: PMC9181281.

144: Huang C, Chu JMT, Liu Y, Kwong VSW, Chang RCC, Wong GTC. Sevoflurane
Induces Neurotoxicity in the Animal Model with Alzheimer's Disease
Neuropathology via Modulating Glutamate Transporter and Neuronal Apoptosis. Int
J Mol Sci. 2022 Jun 2;23(11):6250. doi: 10.3390/ijms23116250. PMID: 35682930;
PMCID: PMC9181124.

145: Chiurchiù V, Tiberi M, Matteocci A, Fazio F, Siffeti H, Saracini S, Mercuri
NB, Sancesario G. Lipidomics of Bioactive Lipids in Alzheimer's and Parkinson's
Diseases: Where Are We? Int J Mol Sci. 2022 Jun 2;23(11):6235. doi:
10.3390/ijms23116235. PMID: 35682914; PMCID: PMC9181703.

146: Santiago JA, Quinn JP, Potashkin JA. Physical Activity Rewires the Human
Brain against Neurodegeneration. Int J Mol Sci. 2022 Jun 2;23(11):6223. doi:
10.3390/ijms23116223. PMID: 35682902; PMCID: PMC9181322.

147: Badaczewska-Dawid AE, Uversky VN, Potoyan DA. BIAPSS: A Comprehensive
Physicochemical Analyzer of Proteins Undergoing Liquid-Liquid Phase Separation.
Int J Mol Sci. 2022 May 31;23(11):6204. doi: 10.3390/ijms23116204. PMID:
35682883; PMCID: PMC9181037.

148: Litus EA, Kazakov AS, Deryusheva EI, Nemashkalova EL, Shevelyova MP,
Machulin AV, Nazipova AA, Permyakova ME, Uversky VN, Permyakov SE. Ibuprofen
Favors Binding of Amyloid-β Peptide to Its Depot, Serum Albumin. Int J Mol Sci.
2022 May 31;23(11):6168. doi: 10.3390/ijms23116168. PMID: 35682848; PMCID:
PMC9181795.

149: Zhang J, Yao P, Han W, Luo Y, Li Y, Yang Y, Xia H, Chen Z, Chen Q, Wang H,
Yang L, Li H, Hu C, Huang H, Peng Z, Tan X, Li M, Yang J. Maternal Prenatal
Inflammation Increases Brain Damage Susceptibility of Lipopolysaccharide in
Adult Rat Offspring via COX-2/PGD-2/DPs Pathway Activation. Int J Mol Sci. 2022
May 30;23(11):6142. doi: 10.3390/ijms23116142. PMID: 35682823; PMCID:
PMC9181626.

150: Gutiérrez IL, Dello Russo C, Novellino F, Caso JR, García-Bueno B, Leza JC,
Madrigal JLM. Noradrenaline in Alzheimer's Disease: A New Potential Therapeutic
Target. Int J Mol Sci. 2022 May 30;23(11):6143. doi: 10.3390/ijms23116143. PMID:
35682822; PMCID: PMC9181823.

151: Ehtewish H, Arredouani A, El-Agnaf O. Diagnostic, Prognostic, and
Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline. Int J
Mol Sci. 2022 May 30;23(11):6144. doi: 10.3390/ijms23116144. PMID: 35682821;
PMCID: PMC9181591.

152: Hindle A, Singh SP, Pradeepkiran JA, Bose C, Vijayan M, Kshirsagar S,
Sawant NA, Reddy PH. Rlip76: An Unexplored Player in Neurodegeneration and
Alzheimer's Disease? Int J Mol Sci. 2022 May 29;23(11):6098. doi:
10.3390/ijms23116098. PMID: 35682775; PMCID: PMC9181721.

153: Pravin N, Jozwiak K. Effects of Linkers and Substitutions on Multitarget
Directed Ligands for Alzheimer's Diseases: Emerging Paradigms and Strategies.
Int J Mol Sci. 2022 May 29;23(11):6085. doi: 10.3390/ijms23116085. PMID:
35682763; PMCID: PMC9181730.

154: Zagorski K, Chailyan G, Hovakimyan A, Antonyan T, Kiani Shabestari S,
Petrushina I, Davtyan H, Cribbs DH, Blurton-Jones M, Masliah E, Agadjanyan MG,
Ghochikyan A. Immunogenicity of MultiTEP-Platform-Based Recombinant Protein
Vaccine, PV-1950R, Targeting Three B-Cell Antigenic Determinants of Pathological
α-Synuclein. Int J Mol Sci. 2022 May 29;23(11):6080. doi: 10.3390/ijms23116080.
PMID: 35682759; PMCID: PMC9181659.

155: Kim J, Jeong M, Stiles WR, Choi HS. Neuroimaging Modalities in Alzheimer's
Disease: Diagnosis and Clinical Features. Int J Mol Sci. 2022 May
28;23(11):6079. doi: 10.3390/ijms23116079. PMID: 35682758; PMCID: PMC9181385.

156: Baidya AT, Kumar A, Kumar R, Darreh-Shori T. Allosteric Binding Sites of Aβ
Peptides on the Acetylcholine Synthesizing Enzyme ChAT as Deduced by In Silico
Molecular Modeling. Int J Mol Sci. 2022 May 28;23(11):6073. doi:
10.3390/ijms23116073. PMID: 35682752; PMCID: PMC9181666.

157: Andrzejewski K, Jampolska M, Mojzych I, Conde SV, Kaczyńska K. Hypoxic and
Hypercapnic Responses in Transgenic Murine Model of Alzheimer's Disease
Overexpressing Human AβPP: The Effects of Pretreatment with Memantine and
Rivastigmine. Int J Mol Sci. 2022 May 26;23(11):6004. doi: 10.3390/ijms23116004.
PMID: 35682682; PMCID: PMC9180806.

158: Qiao H, Zhao W, Guo M, Zhu L, Chen T, Wang J, Xu X, Zhang Z, Wu Y, Chen P.
Cerebral Organoids for Modeling of HSV-1-Induced-Amyloid β Associated
Neuropathology and Phenotypic Rescue. Int J Mol Sci. 2022 May 26;23(11):5981.
doi: 10.3390/ijms23115981. PMID: 35682661; PMCID: PMC9181143.

159: Waseem R, Shamsi A, Khan T, Hassan MI, Kazim SN, Shahid M, Islam A.
Unraveling the Binding Mechanism of Alzheimer's Drugs with Irisin:
Spectroscopic, Calorimetric, and Computational Approaches. Int J Mol Sci. 2022
May 25;23(11):5965. doi: 10.3390/ijms23115965. PMID: 35682643; PMCID:
PMC9180407.

160: Teleanu DM, Niculescu AG, Lungu II, Radu CI, Vladâcenco O, Roza E,
Costăchescu B, Grumezescu AM, Teleanu RI. An Overview of Oxidative Stress,
Neuroinflammation, and Neurodegenerative Diseases. Int J Mol Sci. 2022 May
25;23(11):5938. doi: 10.3390/ijms23115938. PMID: 35682615; PMCID: PMC9180653.

161: Lei C, Wang Q. The Progression of N6-methyladenosine Study and Its Role in
Neuropsychiatric Disorders. Int J Mol Sci. 2022 May 25;23(11):5922. doi:
10.3390/ijms23115922. PMID: 35682599; PMCID: PMC9180340.

162: Vázquez-Villaseñor I, Smith CI, Thang YJR, Heath PR, Wharton SB, Blackburn
DJ, Ridger VC, Simpson JE. RNA-Seq Profiling of Neutrophil-Derived Microvesicles
in Alzheimer's Disease Patients Identifies a miRNA Signature That May Impact
Blood-Brain Barrier Integrity. Int J Mol Sci. 2022 May 25;23(11):5913. doi:
10.3390/ijms23115913. PMID: 35682592; PMCID: PMC9180128.

163: Kim S, Kim DK, Jeong S, Lee J. The Common Cellular Events in the
Neurodegenerative Diseases and the Associated Role of Endoplasmic Reticulum
Stress. Int J Mol Sci. 2022 May 24;23(11):5894. doi: 10.3390/ijms23115894. PMID:
35682574; PMCID: PMC9180188.

164: Han BH, Cofell B, Everhart E, Humpal C, Kang SS, Lee SK, Kim-Han JS.
Amentoflavone Promotes Cellular Uptake and Degradation of Amyloid-Beta in
Neuronal Cells. Int J Mol Sci. 2022 May 24;23(11):5885. doi:
10.3390/ijms23115885. PMID: 35682567; PMCID: PMC9180170.

165: Maciejewska K, Czarnecka K, Kręcisz P, Niedziałek D, Wieczorek G, Skibiński
R, Szymański P. Novel Cyclopentaquinoline and Acridine Analogs as
Multifunctional, Potent Drug Candidates in Alzheimer's Disease. Int J Mol Sci.
2022 May 24;23(11):5876. doi: 10.3390/ijms23115876. PMID: 35682556; PMCID:
PMC9179981.

166: Licastro F. Special Issue Editorial: "Infections, Inflammation and
Neurodegeneration in Alzheimer Disease" Infections, Neuronal Senescence, and
Dementia. Int J Mol Sci. 2022 May 24;23(11):5865. doi: 10.3390/ijms23115865.
PMID: 35682542; PMCID: PMC9180241.

167: Luo CW, Chen SP, Chiang CY, Wu WJ, Chen CJ, Chen WY, Kuan YH. Association
between Ultraviolet B Exposure Levels and Depression in Taiwanese Adults: A
Nested Case-Control Study. Int J Environ Res Public Health. 2022 Jun
3;19(11):6846. doi: 10.3390/ijerph19116846. PMID: 35682430; PMCID: PMC9180491.

168: Perotti P, Bertuccio P, Cacitti S, Deandrea S, Boschetti L, Dalle Carbonare
S, Marguati S, Migliazza S, Porzio E, Riboli S, Cadum E, Cecconami L, Odone A.
Impact of the COVID-19 Pandemic on Total and Cause-Specific Mortality in Pavia,
Northern Italy. Int J Environ Res Public Health. 2022 May 26;19(11):6498. doi:
10.3390/ijerph19116498. PMID: 35682081; PMCID: PMC9180651.

169: Bachmann P, Hruska J. Alzheimer Caregiving Problems According to ADLs:
Evidence from Facebook Support Groups. Int J Environ Res Public Health. 2022 May
25;19(11):6423. doi: 10.3390/ijerph19116423. PMID: 35682011; PMCID: PMC9180182.

170: Kim YA, Kim SH, Joung JY, Yang MS, Back JH, Kim SH. The Insignificant
Correlation between Androgen Deprivation Therapy and Incidence of Dementia Using
an Extension Survival Cox Hazard Model and Propensity-Score Matching Analysis in
a Retrospective, Population-Based Prostate Cancer Registry. Cancers (Basel).
2022 May 30;14(11):2705. doi: 10.3390/cancers14112705. PMID: 35681684; PMCID:
PMC9179880.

171: Butt AM, Rivera AD, Fulton D, Azim K. Targeting the Subventricular Zone to
Promote Myelin Repair in the Aging Brain. Cells. 2022 May 31;11(11):1809. doi:
10.3390/cells11111809. PMID: 35681504; PMCID: PMC9180001.

172: Cosacak MI, Bhattarai P, De Jager PL, Menon V, Tosto G, Kizil C. Single
Cell/Nucleus Transcriptomics Comparison in Zebrafish and Humans Reveals Common
and Distinct Molecular Responses to Alzheimer's Disease. Cells. 2022 May
31;11(11):1807. doi: 10.3390/cells11111807. PMID: 35681503; PMCID: PMC9180693.

173: Kim MW, Choe K, Park JS, Lee HJ, Kang MH, Ahmad R, Kim MO. Pharmacological
Inhibition of Spleen Tyrosine Kinase Suppressed Neuroinflammation and Cognitive
Dysfunction in LPS-Induced Neurodegeneration Model. Cells. 2022 May
28;11(11):1777. doi: 10.3390/cells11111777. PMID: 35681471; PMCID: PMC9179326.

174: Dar NJ, Na R, Ran Q. Functional Deficits of 5×FAD Neural Stem Cells Are
Ameliorated by Glutathione Peroxidase 4. Cells. 2022 May 28;11(11):1770. doi:
10.3390/cells11111770. PMID: 35681465; PMCID: PMC9179411.

175: Bahado-Singh RO, Radhakrishna U, Gordevičius J, Aydas B, Yilmaz A, Jafar F,
Imam K, Maddens M, Challapalli K, Metpally RP, Berrettini WH, Crist RC, Graham
SF, Vishweswaraiah S. Artificial Intelligence and Circulating Cell-Free DNA
Methylation Profiling: Mechanism and Detection of Alzheimer's Disease. Cells.
2022 May 25;11(11):1744. doi: 10.3390/cells11111744. PMID: 35681440; PMCID:
PMC9179874.

176: Yang S, Du Y, Zhao X, Wu C, Yu P. Reducing PDK1/Akt Activity: An Effective
Therapeutic Target in the Treatment of Alzheimer's Disease. Cells. 2022 May
24;11(11):1735. doi: 10.3390/cells11111735. PMID: 35681431; PMCID: PMC9179555.

177: Vidović M, Rikalovic MG. Alpha-Synuclein Aggregation Pathway in Parkinson's
Disease: Current Status and Novel Therapeutic Approaches. Cells. 2022 May
24;11(11):1732. doi: 10.3390/cells11111732. PMID: 35681426; PMCID: PMC9179656.

178: Kondo T, Yada Y, Ikeuchi T, Inoue H. CDiP technology for reverse
engineering of sporadic Alzheimer's disease. J Hum Genet. 2022 Jun 10. doi:
10.1038/s10038-022-01047-8. Epub ahead of print. PMID: 35680997.

179: Reilly M, Benilova I, Khalili-Shirazi A, Schmidt C, Ahmed P, Yip D, Jat PS,
Collinge J. A high-content neuron imaging assay demonstrates inhibition of prion
disease-associated neurotoxicity by an anti-prion protein antibody. Sci Rep.
2022 Jun 9;12(1):9493. doi: 10.1038/s41598-022-13455-z. PMID: 35680944; PMCID:
PMC9184462.

180: Jackson IM, Buccino PJ, Azevedo EC, Carlson ML, Luo ASZ, Deal EM, Kalita M,
Reyes ST, Shao X, Beinat C, Nagy SC, Chaney AM, Anders DA, Scott PJH, Smith M,
Shen B, James ML. Radiosynthesis and initial preclinical evaluation of
[<sup>11</sup>C]AZD1283 as a potential P2Y12R PET radiotracer. Nucl Med Biol.
2022 May 20:S0969-8051(22)00049-X. doi: 10.1016/j.nucmedbio.2022.05.001. Epub
ahead of print. PMID: 35680502.

181: Wyman DL, Butler L, Cooper C, Bright P, Morgan-Trimmer S, Barber J. Process
evaluation of the New Interventions for independence in Dementia Study (NIDUS)
Family stream randomised controlled trial: protocol. BMJ Open. 2022 Jun
9;12(6):e054613. doi: 10.1136/bmjopen-2021-054613. PMID: 35680268; PMCID:
PMC9185390.

182: Chou YH, Sundman M, Ton That V, Green J, Trapani C. Cortical excitability
and plasticity in Alzheimer's disease and mild cognitive impairment: A
systematic review and meta-analysis of transcranial magnetic stimulation
studies. Ageing Res Rev. 2022 Aug;79:101660. doi: 10.1016/j.arr.2022.101660.
Epub 2022 Jun 6. PMID: 35680080.

183: Yang Z, Wang J, Chen J, Luo M, Xie Q, Rong Y, Wu Y, Cao Z, Liu Y. High-
resolution NMR metabolomics of patients with subjective cognitive decline plus:
Perturbations in the metabolism of glucose and branched-chain amino acids.
Neurobiol Dis. 2022 Sep;171:105782. doi: 10.1016/j.nbd.2022.105782. Epub 2022
Jun 6. PMID: 35680005.

184: Lao PJ, Boehme AK, Morales C, Laing KK, Chesebro A, Igwe KC, Gutierrez J,
Gu Y, Stern Y, Schupf N, Manly JJ, Mayeux R, Brickman AM. Amyloid,
cerebrovascular disease, and neurodegeneration biomarkers are associated with
cognitive trajectories in a racially and ethnically diverse, community-based
sample. Neurobiol Aging. 2022 Sep;117:83-96. doi:
10.1016/j.neurobiolaging.2022.05.004. Epub 2022 May 13. PMID: 35679806.

185: Sheykhhasan M, Amini R, Soleimani Asl S, Saidijam M, Hashemi SM, Najafi R.
Neuroprotective effects of coenzyme Q10-loaded exosomes obtained from adipose-
derived stem cells in a rat model of Alzheimer's disease. Biomed Pharmacother.
2022 Aug;152:113224. doi: 10.1016/j.biopha.2022.113224. Epub 2022 Jun 6. PMID:
35679720.

186: Ouyang Y, Li F, Preisser JS, Taljaard M. Sample size calculators for
planning stepped-wedge cluster randomized trials: a review and comparison. Int J
Epidemiol. 2022 Jun 9:dyac123. doi: 10.1093/ije/dyac123. Epub ahead of print.
PMID: 35679584.

187: Lin PJ, Zhu Y, Olchanski N, Cohen JT, Neumann PJ, Faul JD, Fillit HM,
Freund KM. Racial and Ethnic Differences in Hospice Use and Hospitalizations at
End-of-Life Among Medicare Beneficiaries With Dementia. JAMA Netw Open. 2022 Jun
1;5(6):e2216260. doi: 10.1001/jamanetworkopen.2022.16260. PMID: 35679046; PMCID:
PMC9185179.

188: Li F, Zhou SN, Zeng X, Li Z, Yang R, Wang XX, Meng B, Pei WL, Lu L.
Activation of the TREK-1 Potassium Channel Improved Cognitive Deficits in a
Mouse Model of Alzheimer's Disease by Modulating Glutamate Metabolism. Mol
Neurobiol. 2022 Aug;59(8):5193-5206. doi: 10.1007/s12035-022-02776-9. Epub 2022
Jun 9. PMID: 35678977.

189: Zhang GJ, Zheng D, Yu H, Luo XP, Wu W. Ginkgo Biloba Extract Ameliorates
Scopolamine-induced Memory Deficits via Rescuing Synaptic Damage. Curr Med Sci.
2022 Jun;42(3):474-482. doi: 10.1007/s11596-022-2582-8. Epub 2022 Jun 8. PMID:
35678907.

190: Fernandes M, Manfredi N, Aluisantonio L, Franchini F, Chiaravalloti A, Izzi
F, Di Santo S, Schillaci O, Mercuri NB, Placidi F, Liguori C. Cognitive
functioning, cerebrospinal fluid Alzheimer's disease biomarkers and cerebral
glucose metabolism in late-onset epilepsy of unknown aetiology: A prospective
study. Eur J Neurosci. 2022 Jun 9. doi: 10.1111/ejn.15734. Epub ahead of print.
PMID: 35678770.

191: Reuben DB, Evertson LC, Jackson-Stoeckle R, Epstein-Lubow G, Spragens LH,
Haggerty KL, Serrano KS, Jennings LA. Dissemination of a successful dementia
care program: Lessons to facilitate spread of innovations. J Am Geriatr Soc.
2022 Sep;70(9):2686-2694. doi: 10.1111/jgs.17900. Epub 2022 Jun 9. PMID:
35678747; PMCID: PMC9489616.

192: Russo M, Amboni M, Volzone A, Ricciardelli G, Cesarelli G, Ponsiglione AM,
Barone P, Romano M, Ricciardi C. Interplay between gait and neuropsychiatric
symptoms in Parkinson's Disease. Eur J Transl Myol. 2022 Jun 7;32(2):10463. doi:
10.4081/ejtm.2022.10463. PMID: 35678506; PMCID: PMC9295172.

193: Rose RV, Kass JS. The Medicolegal and Ethical Dimensions of Physician
Prescription Reluctance. Continuum (Minneap Minn). 2022 Jun 1;28(3):937-941.
doi: 10.1212/CON.0000000000001164. PMID: 35678410.

194: Carlsson CM. Management of Dementia. Continuum (Minneap Minn). 2022 Jun
1;28(3):885-900. doi: 10.1212/CON.0000000000001132. PMID: 35678408.

195: Balls-Berry JJE, Babulal GM. Health Disparities in Dementia. Continuum
(Minneap Minn). 2022 Jun 1;28(3):872-884. doi: 10.1212/CON.0000000000001088.
PMID: 35678407.

196: Jayadev S. Genetics of Alzheimer Disease. Continuum (Minneap Minn). 2022
Jun 1;28(3):852-871. doi: 10.1212/CON.0000000000001125. PMID: 35678406.

197: Schneider JA. Neuropathology of Dementia Disorders. Continuum (Minneap
Minn). 2022 Jun 1;28(3):834-851. doi: 10.1212/CON.0000000000001137. PMID:
35678405.

198: Schindler SE. Fluid Biomarkers in Dementia Diagnosis. Continuum (Minneap
Minn). 2022 Jun 1;28(3):822-833. doi: 10.1212/CON.0000000000001083. PMID:
35678404.

199: Raji CA, Benzinger TLS. The Value of Neuroimaging in Dementia Diagnosis.
Continuum (Minneap Minn). 2022 Jun 1;28(3):800-821. doi:
10.1212/CON.0000000000001133. PMID: 35678403.

200: Weintraub S. Neuropsychological Assessment in Dementia Diagnosis. Continuum
(Minneap Minn). 2022 Jun 1;28(3):781-799. doi: 10.1212/CON.0000000000001135.
PMID: 35678402; PMCID: PMC9492323.